Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Receivables - Other: 2018-2021

Historic Receivables - Other for Wave Life Sciences (WVE) over the last 3 years, with Mar 2021 value amounting to $30.0 million.

  • Wave Life Sciences' Receivables - Other changed negligibly% to $30.0 million in Q1 2021 from the same period last year, while for Mar 2021 it was $30.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $30.0 million for FY2020, which is 40.00% down from last year.
  • As of Q1 2021, Wave Life Sciences' Receivables - Other stood at $30.0 million, which was down 0.00% from $30.0 million recorded in Q4 2020.
  • In the past 5 years, Wave Life Sciences' Receivables - Other ranged from a high of $60.0 million in Q2 2018 and a low of $30.0 million during Q1 2020.
  • Moreover, its 3-year median value for Receivables - Other was $30.0 million (2021), whereas its average is $40.0 million.
  • Data for Wave Life Sciences' Receivables - Other shows a maximum YoY tumbled of 50.00% (in 2020) over the last 5 years.
  • Over the past 4 years, Wave Life Sciences' Receivables - Other (Quarterly) stood at $60.0 million in 2018, then fell by 16.67% to $50.0 million in 2019, then tumbled by 40.00% to $30.0 million in 2020, then remained steady at $30.0 million in 2021.
  • Its Receivables - Other was $30.0 million in Q1 2021, compared to $30.0 million in Q4 2020 and $30.0 million in Q3 2020.